S. Muoio & Co’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62,000
Closed -$1.74M 93
2022
Q1
$1.74M Buy
62,000
+37,000
+148% +$1.01M 2.05% 15
2021
Q4
$683K Hold
25,000
0.27% 52
2021
Q3
$680K Buy
+25,000
New +$618K 0.52% 58

S. Muoio & Co's XENT Position: Q2 2022 in Review

S. Muoio & Co sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 62,000 shares — an estimated $1.74M sold.

S. Muoio & Co first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $1.74M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • S. Muoio & Co reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • S. Muoio & Co sold 62,000 Intersect ENT, Inc shares in Q2 2022, an estimated $1.74M.
  • S. Muoio & Co first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • S. Muoio & Co's Intersect ENT, Inc position peaked at $1.74M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on S. Muoio & Co's 13F filing for Q2 2022, filed 15 Aug 2022.